The utility of exoantigens for detection of Leishmania infections

Military Medicine

Volumn 172, Issue 5, 2007, Pages 482-485

  Rajasekariah, G Halli R ^a   Smithyman, Anthony M ^a   Gupta, Raj K ^c   Martin, Samuel K ^b  

^a Mahidol University   (Thailand)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HOST PARASITE INTERACTION; HUMAN; INCIDENCE; LEISHMANIA; LEISHMANIASIS; MICROORGANISM DETECTION; PARASITE VECTOR; PROMASTIGOTE; SERODIAGNOSIS;

EID: 34248524993     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.172.5.482     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention: Viscerotropic leishmaniasis in persons returning from Operation Desert Storm, 1990-1991. MMWR 1992; 41: 131-4.
2. Bradshaw WL: Guidance for the Diagnosis and Treatment of Leishmania Infection. Information letter 2004-013. Kansas City, MO, Veterans of Foreign Wars, 2004. Available at http://www.vfwdc.org/NVS/ Technical%20Info%20bulliten/ 20041021%20TIB.htm: accessed May 9, 2005.
3. World Health Organization: Leishmaniasis. Available at http://www.who.int/ tdr/diseases/leish/default.htmasterisk inside circle signasterisk inside circle signasterisk inside circle sign.
4. Perlin JB: Guidance for the Diagnosis and Treatment of Leishmania infection: Under Secretary for Health's Information Letter. Report IL10-2004-013. Washington, DC, Veterans Administration, 2004.
5. Desjeux P: The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 2001; 95: 239-43.
6. Rose K, Curtis J, Baldwin T, et al: Cutaneous leishmaniasis in red kangaroos: isolation and characterization of the causative organisms. Int J Parasitol 2004; 34: 655-64.
7. Gaskin AA, Schantz P, Jackson J, et al: Visceral leishmaniasis in a New York foxhound kennel. J Vet Intern Med 2002; 16: 34-44.
8. Momen H: Emerging infectious diseases: Brazil. Emerg Infect Dis 1998; 4: 1-3.
9. Arias JR, Monteiro PS, Zicker F: The reemergence of visceral leishmaniasis in Brazil. Emerg Infect Dis 1996; 2: 145-6.
10. Martin S, Gambel J, Jackson J, et al: Leishmaniasis in the United States military. Milit Med 1998; 163: 801-7.
11. Aronson N, Coleman R, Coyne P, et al: Cutaneous leishmaniasis in U.S. military personnel: Southwest/Central Asia, 2002-2003. MMWR 2003; 52: 1009-12.
12. Bureau of Medicine: Medical Situation Report One: Leishmaniasis CY04. Washington, DC, Bureau of Medicine, 2004. Available at http://www.nehc.med.navy. mil/prevmed/ento/1Leish04.txt.
13. Repaci P: Update: Leishmaniasis among Soldiers Deployed to OIF/OEF. Publication DASG-PPM-NC/681-2949. April 28, 2005.
14. Vogrin CL: The Gazette media report: rare parasite infection afflicts U.S. troops in Iraq, April 15, 2005. Available at http://www.kentucky.com/mld/ kentucky/ news/breaking_news/11402394.htm?template=contentModule; accessed May 30, 2005.
15. Hecht F, Hecht B: Leishmania comes home with troops. Available at http:// www.medicinenet.com/script/main/art.asp?articlekey=249194pf=3.
16. Centers for Disease Control and Prevention: Cutaneous leishmaniasis in U.S. military personnel: Southwest/Central Asia, 2002-2003. MMWR 2003; 52: 1009-12.
17. Rodriguez AJ: Leishmaniasis in military troops: Colombia, 2005. Available at http://www.promedmail.org; accessed February 3, 2005.
18. Magill AJ, Grogl M, Gasser RA, Sun W, Oster CN: Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1999; 328: 1383-7.
19. Iovino LA Jr: Leishmaniasis recurrence after 43 years may be longest on record. Available at http://www.infectiousdiseasenews.com/200002/leish.asp; accessed March 23, 2006.
20. Rajasekariah GR, Ryan JR, Hiller SR, et al: Optimisation of an ELISA for the serodiagnosis of visceral leishmaniasis using in vitro derived promastigote antigens. J Immunol Methods 2001; 252: 105-9.
21. Ryan JR, Smithyman AM, Rajasekariah GR, Hochberg L, Stiteler JM, Martin SK: Enzyme-linked immunosorbent assay based soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis. J Clin Microbiol 2002; 40: 1037-43.
22. Tonui WK, Mejia JS, Hochberg L, et al: Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major. Infect Immun 2004; 72: 5654-61.
23. Cui L, Rajasekariah GR, Martin SK: A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite. Gene 2001; 280: 153-62.
24. 2 reductase in Leishmania. Int J Parasitol 2002; 33: 221-8.
25. Coleman R, McAvin JC, Putnam JL et al: Assessment of sandflies as a means of evaluating the threat of leishmaniasis to military forces deployed in Iraq and Afghanistan. Annual meeting Entomological Society of America,December 13, 2006. Available at http://esa.confex.com/esa/2006/techprogram/paper_23764. htm.
26. Roscoe MR: Leishmaniasis: early diagnosis is key. JAAPA 2005; 18: 47-54.